We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+16.68%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$88.8B
AUM Growth
+$10B
(+13%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
31.47%
Holding
3,325
New
753
Increased
947
Reduced
893
Closed
691
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRCL
Circle Internet Group
CRCL
|
+$1.39B |
| 2 |
NVIDIA
NVDA
|
+$910M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
T-Mobile US
TMUS
|
+$432M |
| 5 |
Eli Lilly
LLY
|
+$398M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.3B |
| 2 |
Tesla
TSLA
|
+$880M |
| 3 |
Danaher
DHR
|
+$535M |
| 4 |
Intuit
INTU
|
+$467M |
| 5 |
Visa
V
|
+$437M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.88% |
| 2 | Consumer Discretionary | 13.54% |
| 3 | Healthcare | 10.42% |
| 4 | Financials | 8.78% |
| 5 | Communication Services | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Verrica Pharmaceuticals
VRCA
$91.7M
| $65.7K | ﹤0.01% |
+12,395
| New | +$66.7K |
|
2552
Galectin Therapeutics
GALT
$323M
| $64.1K | ﹤0.01% |
+30,400
| New | +$45.5K |
|
2553
Fuel Tech
FTEK
$43.4M
| $63.2K | ﹤0.01% |
+25,088
| New | +$35.8K |
|
2554
BuzzFeed
BZFD
$95.8M
| $63K | ﹤0.01% |
31,522
-35,906
| -53% | -$70.9K |
|
2555
CEMIG Preferred Shares
CIG
$5.89B
| $61.9K | ﹤0.01% |
+31,575
| New | +$57.8K |
|
2556
Biomea Fusion
BMEA
$91.3M
| $61.6K | ﹤0.01% |
34,216
+5,750
| +20% | +$11.1K |
|
2557
KraneShares CSI China Internet ETF
KWEB
$5.75B
| $61.4K | ﹤0.01% |
1,789
-163,364
| -99% | -$5.41M |
|
2558
Harvard Bioscience
HBIO
$30.1M
| $61K | ﹤0.01% |
+13,870
| New | +$58K |
|
2559
Cardlytics
CDLX
$22.4M
| $59.2K | ﹤0.01% |
+3,590
| New | +$62K |
|
2560
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $58.3K | ﹤0.01% |
+912
| New | +$58.1K |
|
2561
Lumen
LUMN
$6.78B
| $58.3K | ﹤0.01% |
13,300
| – | – |
|
2562
CALL
JPMorgan Chase
JPM
$953B
| $58K | ﹤0.01% |
+200
| New | +$51K |
|
|
ELEV
2563
DELISTED
Elevation Oncology
ELEV
| $57.3K | ﹤0.01% |
+154,793
| New | +$51.7K |
|
|
MRDN
2564
Meridian Holdings Inc
MRDN
$175M
| $57K | ﹤0.01% |
+2,792
| New | +$60.7K |
|
2565
374Water
SCWO
$38.5M
| $56.8K | ﹤0.01% |
+17,740
| New | +$59.6K |
|
2566
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$237M
| $56.5K | ﹤0.01% |
1,100
-28,900
| -96% | -$1.44M |
|
|
SATX
2567
DELISTED
SatixFy Communications
SATX
| $56.1K | ﹤0.01% |
+19,151
| New | +$46.3K |
|
|
UHG
2568
DELISTED
United Homes Group
UHG
| $55.8K | ﹤0.01% |
+19,228
| New | +$50K |
|
2569
Olema Pharmaceuticals
OLMA
$1.04B
| $54.5K | ﹤0.01% |
12,800
-307,150
| -96% | -$1.37M |
|
2570
Ovid Therapeutics
OVID
$478M
| $54.4K | ﹤0.01% |
+164,721
| New | +$49.6K |
|
2571
LG Display
LPL
$3.4B
| $53.8K | ﹤0.01% |
+15,745
| New | +$48.7K |
|
2572
1stdibs.com
DIBS
$159M
| $52.7K | ﹤0.01% |
19,153
+7,168
| +60% | +$18.6K |
|
2573
CarParts.com
PRTS
$52.7M
| $50.7K | ﹤0.01% |
6,855
+5,317
| +346% | +$45.4K |
|
2574
Rafael Holdings
RFL
$100M
| $49.7K | ﹤0.01% |
+28,700
| New | +$46.8K |
|
|
IGMS
2575
DELISTED
IGM Biosciences
IGMS
| $49.6K | ﹤0.01% |
+44,287
| New | +$54.1K |
|
Similar funds
Marshall Wace's Q2 2025 Portfolio in Review
As of Q2 2025, Marshall Wace held 3,325 positions worth $88.8B, up 13% from $78.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marshall Wace's Q2 2025 filing shows 753 new, 947 increased, 893 reduced and 691 closed positions. Its largest new stake was Circle Internet Group: 8,534,470 shares worth $1.55B. The largest sale was iShares Core S&P 500 ETF, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q2 2025 buy was Circle Internet Group: 8,534,470 shares worth $1.55B.
- Marshall Wace added most to NVIDIA in Q2 2025, an estimated $910M increase.
- Marshall Wace's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.3B.
- Marshall Wace fully exited Cboe Global Markets in Q2 2025, selling an estimated $191M.
- Marshall Wace's ten largest holdings make up 31% of its $88.8B portfolio in Q2 2025.
- Marshall Wace opened 753 new positions and closed 691 in Q2 2025.
- Marshall Wace's portfolio value rose 13% quarter-over-quarter to $88.8B.
Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.